Emory Alzheimer's Disease Research Center
Emory Alzheimer's Disease Research Center
批准号:
10212234
负责人:
Thomas Spurgeon Wingo
金额:
$43.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-15 至 2025-04-30
关键词:
Alzheimer&aposs DiseaseAlzheimer&aposs disease riskAlzheimer&aposs disease therapyAlzheimer’s disease biomarkerAmyloid beta-42AreaBiological AssayBiological MarkersBrainBrain imagingChronic DiseaseClinicalClinical TrialsCollectionCommunitiesComplementConsultDNA ResequencingDataData AnalysesData MartData SetDatabasesDementiaDiagnosisDiseaseElementsEligibility DeterminationEnsureEnvironmentEtiologyFoundationsFundingGenesGeneticGenotypeGoalsHumanIndividualInheritedInterventionLearningMagnetic Resonance ImagingMethodsParticipantPathologyPopulationPositron-Emission TomographyProceduresProcessProteomicsProtocols documentationQuality ControlRaceResearchResearch ActivityResearch PersonnelResearch SupportSamplingServicesStandardizationSystemTalentsTestingWorkbasebiomarker discoverycandidate markercohortcomplex datagenetic analysisgenetic informationgenetic profilinggenomic datagenotypic sexinnovationmild cognitive impairmentmutation carrierneuroimagingneuropathologynovel markerprognosticrecruitrepositoryresponserisk variantserial imagingtau Proteinstau-1toolwhole genome
中文摘要
摘要/摘要:生物标志物核心
阿尔茨海默病(AD)是一种慢性疾病,会在漫长的无症状期内进展
在进入轻度认知障碍(MCI)和痴呆期之前。使用当前的生物标记物
工具,我们可以相当有把握地确定是否存在AD相关的病理
在一个活着的个体身上。然而,AD生物标记物的能力仍然存在重大限制,并且
迫切需要新的生物标记物来克服剩余的障碍。建议的生物标记物
CORE将通过追求三个具体目标来支持埃默里ADRC的研究活动:1)执行
分析标准化遗传图谱,发掘有潜力的候选者;2)执行和分析
标准化的脑脊液AD生物标记物分析和发掘有前途的候选者;3)执行和分析
标准的脑成像和评估有前景的附加序列。建议的生物标志物核心
将为研究环境提供一些重要的改进。纵向采集
公共数据集,包括临床信息、脑脊液AD生物标志物、核心遗传信息和
标准的脑MRI序列将提供测试新的AD生物标记物的基础,
评估并确认。每一个领域的探索性研究都应该提供有意义的
脑脊液蛋白质组学、新的磁共振序列和基因组数据的进展。最后,目前的提案
聘请一群才华横溢的调查人员,他们将把他们的专业知识带给ADRC和更大的
研究社区。这些要素中的每一个都推进了非盟的总体目标,并将提供一种
为新学员提供丰富的数据。
英文摘要
SUMMARY/ABSTRACT: BIOMARKER CORE
Alzheimer’s disease (AD) is a chronic disease that progresses through a lengthy asymptomatic period
before entering a period of mild cognitive impairment (MCI) and dementia. Using current biomarker
tools, we can determine with a fair degree of confidence whether or not AD-related pathology is present
in a living individual. However, there remain major limitations in the capabilities of AD biomarkers, and
there is a critical need for new biomarkers to overcome remaining barriers. The proposed Biomarker
Core will support research activities in the Emory ADRC by pursuing three Specific Aims: 1) Perform
and analyze standardized genetic profiling and explore promising candidates; 2) Perform and analyze
standardized CSF AD biomarker assays and explore promising candidates; 3) Perform and analyze
standard brain imaging and evaluate promising additional sequences. The proposed Biomarker Core
will provide a number of important enhancements to the research environment. Longitudinal collection
of common datasets, including clinical information, CSF AD biomarkers, core genetic information, and
standard brain MRI sequences, will provide foundations upon which new AD biomarkers can be tested,
evaluated, and confirmed. Exploratory research in each of these areas should provide significant
advances in CSF proteomics, new MR sequences, and genomic data. Lastly, the current proposal
engages a group of talented investigators who will bring their expertise to the ADRC and the larger
research community. Each of these elements advance the overall goals of the ADRC and will provide a
wealth of data for new trainees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Emory Alzheimer's Disease Research Center
-
批准号:10408026
-
项目类别:
-
资助金额:$42.18万
-
财政年份:2020
-
负责人:Thomas Spurgeon Wingo
-
依托单位:
Emory Alzheimer's Disease Research Center
-
批准号:10673952
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2020
-
负责人:Thomas Spurgeon Wingo
-
依托单位:
A Genetic Study of a Large Pedigree with Late-onset Alzheimer's Disease
-
批准号:8764628
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Thomas Spurgeon Wingo
-
依托单位:
A Genetic Study of a Large Pedigree with Late-onset Alzheimer's Disease
-
批准号:8541314
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Thomas Spurgeon Wingo
-
依托单位:
A Genetic Study of a Large Pedigree with Late-onset Alzheimer's Disease
-
批准号:9223625
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Thomas Spurgeon Wingo
-
依托单位:
A Genetic Study of a Large Pedigree with Late-onset Alzheimer's Disease
-
批准号:8966632
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Thomas Spurgeon Wingo
-
依托单位:
A Proteogenomic Approach to Understanding AD GWAS Results
-
批准号:9088277
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2005
-
负责人:Thomas Spurgeon Wingo
-
依托单位:
Emory Alzheimer's Disease Research Center
-
批准号:9921948
-
项目类别:
-
资助金额:$53.77万
-
财政年份:--
-
负责人:Thomas Spurgeon Wingo
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: